Literature DB >> 33498362

Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies.

Chiara Briani1, Sergio Ferrari2, Marta Campagnolo1, Matteo Tagliapietra2, Francesca Castellani1, Alessandro Salvalaggio1, Sara Mariotto2, Andrea Visentin3, Tiziana Cavallaro2.   

Abstract

Despite the introduction of non-invasive techniques in the study of peripheral neuropathies, sural nerve biopsy remains the gold standard for the diagnosis of several neuropathies, including vasculitic neuropathy and neurolymphomatosis. Besides its diagnostic role, sural nerve biopsy has helped to shed light on the pathogenic mechanisms of different neuropathies. In the present review, we discuss how pathological findings helped understand the mechanisms of polyneuropathies complicating hematological diseases.

Entities:  

Keywords:  lymphoma; monoclonal gammopathy; neurolymphomatosis; peripheral neuropathy; sural nerve biopsy

Year:  2021        PMID: 33498362     DOI: 10.3390/brainsci11020132

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  4 in total

1.  The Clinical Spectrum of Autoimmune-Mediated Neurological Diseases in Paediatric Population.

Authors:  Karol Lubarski; Anna Mania; Sławomir Michalak; Krystyna Osztynowicz; Katarzyna Mazur-Melewska; Magdalena Figlerowicz
Journal:  Brain Sci       Date:  2022-04-29

2.  Nerve Biopsy in Peripheral Neuropathies: Not All Water Is under the Bridge.

Authors:  Marco Luigetti; Andrea Di Paolantonio
Journal:  Brain Sci       Date:  2021-04-27

Review 3.  Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies.

Authors:  Chiara Briani; Andrea Visentin
Journal:  Neurotherapeutics       Date:  2022-03-28       Impact factor: 6.088

Review 4.  From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.

Authors:  Andrea Visentin; Stefano Pravato; Francesca Castellani; Marta Campagnolo; Francesco Angotzi; Chiara Adele Cavarretta; Alessandro Cellini; Valeria Ruocco; Alessandro Salvalaggio; Alessandra Tedeschi; Livio Trentin; Chiara Briani
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.